Alopecia Areata — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

HardHair DisordersAlopecia AreataSCE Dermatology

A 16-year-old has severe alopecia areata with 70% scalp hair loss despite potent topical corticosteroid treatment. Which oral targeted treatment has a UK recommendation for severe disease in people aged 12 years and over?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Ritlecitinib

Ritlecitinib is an oral JAK3/TEC-family kinase inhibitor recommended in UK practice for severe alopecia areata in people aged 12 years and over when systemic treatment is appropriate. The other listed kinase inhibitors do not share that specific UK alopecia-areata indication across this age group.

Reference: https://academic.oup.com/bjd/article/192/2/190/7829170